C
TransMedics Group, Inc. TMDX
$125.74 -$2.76-2.15% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 2,288.73% 580.13% 241.70% 191.22% 116.87%
Total Depreciation and Amortization 64.77% 92.93% 141.63% 201.91% 196.58%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -25.58% -23.17% -19.91% -28.70% 229.75%
Change in Net Operating Assets 56.55% -0.42% -1.47% -11.49% -33.80%
Cash from Operations 386.00% 732.95% 474.60% 247.61% 172.36%
Capital Expenditure 54.97% 42.28% 14.56% -40.04% -2,618.10%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions 102.96% 102.96% 102.96% 102.96% --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- 100.00% -198.32%
Cash from Investing 62.45% 52.71% 33.33% -1.69% -1,419.21%
Total Debt Issued -- -- -- -100.00% -100.00%
Total Debt Repaid -- -- -- 100.00% 100.00%
Issuance of Common Stock 17.77% 258.48% 221.72% 144.43% -89.11%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- 100.00% 100.00%
Cash from Financing 17.77% -94.32% -94.29% -94.38% -97.12%
Foreign Exchange rate Adjustments 821.67% 90.57% -377.72% 24.79% -53.85%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 117.22% -125.92% -130.04% -143.57% -139.80%